Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.02 USD | +1.14% | -0.31% | +30.41% |
05-02 | Argan: Mr. Le Lan and Kerlan below 30% of share capital & voting rights | CF |
04-24 | Argan: successful 150 ME capital increase | CF |
Valuation
Fiscal Period: Enero | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 658.3 | 678.3 | 583.8 | 529.3 | 590.8 | 814.7 | - |
Enterprise Value (EV) 1 | 658.3 | 678.3 | 583.8 | 203.9 | 590.8 | 814.7 | 814.7 |
P/E ratio | -15.4 x | 28.6 x | 15.5 x | 16.7 x | 18.5 x | 16.4 x | 13.7 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 2.75 x | 1.73 x | 1.15 x | 1.16 x | 1.03 x | 1.12 x | 0.99 x |
EV / Revenue | 2.75 x | 1.73 x | 1.15 x | 1.16 x | 1.03 x | 1.12 x | 0.99 x |
EV / EBITDA | -14.6 x | 23 x | 9.46 x | 11 x | 11.5 x | 12 x | 10.8 x |
EV / FCF | 14.2 x | 3.92 x | 21.6 x | -15.8 x | - | 14.2 x | 14.9 x |
FCF Yield | 7.06% | 25.5% | 4.62% | -6.32% | - | 7.03% | 6.71% |
Price to Book | - | - | - | 1.97 x | - | - | - |
Nbr of stocks (in thousands) | 15,633 | 15,690 | 15,715 | 13,576 | 13,328 | 13,351 | - |
Reference price 2 | 42.11 | 43.23 | 37.15 | 38.99 | 44.33 | 61.02 | 61.02 |
Announcement Date | 20-04-14 | 21-04-14 | 22-04-13 | 23-04-12 | 24-04-11 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: Enero | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 239 | 392.2 | 509.4 | 455 | 573.3 | 724.4 | 822.4 |
EBITDA 1 | -45.09 | 29.54 | 61.74 | 48.11 | 51.34 | 68 | 75.4 |
EBIT 1 | -50.94 | 23.03 | 52.41 | 41.67 | 36.46 | 51.5 | 66.05 |
Operating Margin | -21.32% | 5.87% | 10.29% | 9.16% | 6.36% | 7.11% | 8.03% |
Earnings before Tax (EBT) 1 | -47.76 | 24.88 | 47.06 | 46 | 48.93 | 66.5 | 79.3 |
Net income 1 | -42.69 | 23.85 | 38.24 | 33.1 | 32.36 | 49.8 | 59.35 |
Net margin | -17.86% | 6.08% | 7.51% | 7.27% | 5.64% | 6.88% | 7.22% |
EPS 2 | -2.730 | 1.510 | 2.400 | 2.330 | 2.390 | 3.730 | 4.465 |
Free Cash Flow 1 | 46.51 | 173 | 26.99 | -33.43 | - | 57.3 | 54.7 |
FCF margin | 19.46% | 44.11% | 5.3% | -7.35% | - | 7.91% | 6.65% |
FCF Conversion (EBITDA) | - | 585.51% | 43.72% | - | - | 84.26% | 72.55% |
FCF Conversion (Net income) | - | 725.27% | 70.58% | - | - | 115.06% | 92.17% |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 20-04-14 | 21-04-14 | 22-04-13 | 23-04-12 | 24-04-11 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: Januar | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 124.5 | 125.6 | 100.3 | 118.1 | 117.9 | 118.8 | 103.7 | 141.3 | 163.8 | 164.6 | 134.8 | 172.1 | 196 | 221.5 | 191.7 |
EBITDA 1 | 16.71 | 11.24 | 10.73 | 14.89 | 11.26 | 11.23 | 3.649 | 17.94 | 12.18 | 17.56 | 10.3 | 16.4 | 18.2 | 23.3 | - |
EBIT 1 | 14.54 | 6.723 | 9.163 | 13.4 | 9.541 | 9.562 | 3.633 | 13.24 | 7.86 | 11.72 | 5.5 | 11.4 | 15 | 19.55 | - |
Operating Margin | 11.69% | 5.35% | 9.14% | 11.35% | 8.09% | 8.05% | 3.5% | 9.37% | 4.8% | 7.12% | 4.08% | 6.62% | 7.66% | 8.83% | - |
Earnings before Tax (EBT) 1 | 15.66 | -0.195 | 9.758 | 13.91 | 10.31 | 12.02 | 3.004 | 17.36 | 11.59 | 16.98 | 9.25 | 15.15 | 18.75 | 23.3 | - |
Net income 1 | 12.39 | 2.215 | 7.485 | 4.222 | 7.758 | 13.63 | 2.109 | 12.77 | 5.464 | 12.02 | 6.95 | 11.35 | 14.05 | 17.45 | - |
Net margin | 9.96% | 1.76% | 7.46% | 3.57% | 6.58% | 11.48% | 2.03% | 9.03% | 3.34% | 7.3% | 5.16% | 6.6% | 7.17% | 7.88% | - |
EPS 2 | 0.7800 | 0.1400 | 0.5000 | 0.3000 | 0.5600 | 1.000 | 0.1600 | 0.9400 | 0.4000 | 0.8900 | 0.5200 | 0.8500 | 1.050 | 1.305 | 1.040 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 21-12-08 | 22-04-13 | 22-06-08 | 22-09-08 | 22-12-07 | 23-04-12 | 23-06-08 | 23-09-06 | 23-12-06 | 24-04-11 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: Januar | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | 325 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | 46.5 | 173 | 27 | -33.4 | - | 57.3 | 54.7 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | 19.80 | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | 7.06 | 1.7 | 1.42 | 3.37 | - | 2.1 | 5.05 |
Capex / Sales | 2.95% | 0.43% | 0.28% | 0.74% | - | 0.29% | 0.61% |
Announcement Date | 20-04-14 | 21-04-14 | 22-04-13 | 23-04-12 | 24-04-11 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.41% | 815M | |
-0.79% | 59.25B | |
+18.16% | 37.33B | |
+11.43% | 30.82B | |
+3.94% | 26.69B | |
+15.67% | 20.69B | |
+15.21% | 19.47B | |
+22.41% | 16.97B | |
+65.39% | 16.74B | |
+11.43% | 14.81B |
- Stock Market
- Equities
- AGX Stock
- Financials Argan, Inc.